Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 11, Number 6—June 2005

Research

Community Prescribing and Resistant Streptococcus pneumoniae

Galia Barkai*, David Greenberg*, Noga Givon-Lavi*, Eli Dreifuss†, Daniel Vardy†, and Ron Dagan*Comments to Author 
Author affiliations: *Soroka University Medical Center and Ben-Gurion University of the Negev, Beer-Sheva, Israel; †Israel General Health Insurance Plan, Beer-Sheva, Israel

Main Article

Table

Antimicrobial drug prescriptions among Bedouin and Jewish children <5 years of age, southern Israel, 1998–2003

Antimicrobial agent Bedouin children
Jewish children
Total prescriptions Mean ± SD yearly prescription rate/1,000 children Total prescriptions Mean ± SD yearly prescription rate/1,000 children Mean ± SD yearly difference (Bedouin children vs. Jewish children)/prescription/1,000 children p value
Amoxicillin 89,598 2,269 ± 266 54,090 1,480 ± 264 789 ± 175 <0.001
Amoxicillin-clavulanate 27,729 703 ± 91 12,173 335 ± 88 368 ± 51 <0.001
Phenoxymethyl penicillin 3,187 84 ± 47 3,609 101 ± 47 –16 ± 10 0.012
Cephalosporins* 18,625 471 ± 69 5,751 155 ± 34 316 ± 66 <0.001
Erythromycin 3,492 92 ± 51 2,256 64 ± 45 28 ± 66 0.002
Azithromycin 6,958 167 ± 108 8,998 236 ± 124 –70 ± 49 0.018
Total 149,589 3,787 ± 442 86,877 2,371 ± 315 1,416 ± 224 <0.001

*Cefaclor, cephalexin monohydrate, and cefuroxime-axetil.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO